About Intellectual Property IP Training IP Outreach IP for… IP and... IP in... Patent & Technology Information Trademark Information Industrial Design Information Geographical Indication Information Plant Variety Information (UPOV) IP Laws, Treaties & Judgements IP Resources IP Reports Patent Protection Trademark Protection Industrial Design Protection Geographical Indication Protection Plant Variety Protection (UPOV) IP Dispute Resolution IP Office Business Solutions Paying for IP Services Negotiation & Decision-Making Development Cooperation Innovation Support Public-Private Partnerships The Organization Working with WIPO Accountability Patents Trademarks Industrial Designs Geographical Indications Copyright Trade Secrets WIPO Academy Workshops & Seminars World IP Day WIPO Magazine Raising Awareness Case Studies & Success Stories IP News WIPO Awards Business Universities Indigenous Peoples Judiciaries Genetic Resources, Traditional Knowledge and Traditional Cultural Expressions Economics Gender Equality Global Health Climate Change Competition Policy Sustainable Development Goals Enforcement Frontier Technologies Mobile Applications Sports Tourism PATENTSCOPE Patent Analytics International Patent Classification ARDI – Research for Innovation ASPI – Specialized Patent Information Global Brand Database Madrid Monitor Article 6ter Express Database Nice Classification Vienna Classification Global Design Database International Designs Bulletin Hague Express Database Locarno Classification Lisbon Express Database Global Brand Database for GIs PLUTO Plant Variety Database GENIE Database WIPO-Administered Treaties WIPO Lex - IP Laws, Treaties & Judgments WIPO Standards IP Statistics WIPO Pearl (Terminology) WIPO Publications Country IP Profiles WIPO Knowledge Center WIPO Technology Trends Global Innovation Index World Intellectual Property Report PCT – The International Patent System ePCT Budapest – The International Microorganism Deposit System Madrid – The International Trademark System eMadrid Article 6ter (armorial bearings, flags, state emblems) Hague – The International Design System eHague Lisbon – The International System of Appellations of Origin and Geographical Indications eLisbon UPOV PRISMA Mediation Arbitration Expert Determination Domain Name Disputes Centralized Access to Search and Examination (CASE) Digital Access Service (DAS) WIPO Pay Current Account at WIPO WIPO Assemblies Standing Committees Calendar of Meetings WIPO Official Documents Development Agenda Technical Assistance IP Training Institutions COVID-19 Support National IP Strategies Policy & Legislative Advice Cooperation Hub Technology and Innovation Support Centers (TISC) Technology Transfer Inventor Assistance Program WIPO GREEN WIPO's Pat-INFORMED Accessible Books Consortium WIPO for Creators WIPO ALERT Member States Observers Director General Activities by Unit External Offices Job Vacancies Procurement Results & Budget Financial Reporting Oversight

[process2-comments] RFC-3

To: process.mail@wipo.int
From: "Luis de Barros"
Subject: RFC-3
Date: Thu, 14 Jun 2001 19:56:10 +0200

Name: Luis de Barros
Organization: Radius Works
Position: Technical Specialist

I have to object to the use of INNs for Pharmaceutical Substances. While I think that the WHO has done an enormous amount of good work, they have no business in deciding which domain names (and variations) can or cannot be registered.

The mis-use of pharmaceutical/medical domains is a fact of life. Everyone is mis-informing their visitors in order to sell their products. Happened to me when I bought my last car at the Ford dealership. It's the individuals responsibility to investigate and do proper research. There are trusted and valid medical sites that provide valuable information. Instead of blocking the registration (and most likely the renewal) of INN domains, why not create sites that inform the consumer? WHO should take the initiative and make its responsibility to be THE source and along with pharmaceutical companies take legal action against irresponsible individuals.

WHO should work with governments to ensure that proper medical information is provided. If someone has the domain www.aspirin.com and has a gallery of her collection of Aspirin bottles dating back to the 1940 then more power to her. The domain filtering won't help other sites, such as someone suggesting to ingest 20 aspirins followed by a shot of Vodka can still reside on www.geocities.com site.

The first come, first serve idea should be the basis for domains. INNs are not going to solve the problems that WHO mentions.

Thank you,

Luis de Barros